AAIC 2025 Abstract
Prognostic and Disease Tracking Capability of Light Reflex Pupillometry and Actigraphy in Early Alzheimer's Disease
By Mathias Holsey Gramkow, Frederikke Kragh Clemmensen, Andreas Brink-Kjær, Show 6 more authorsKristian Steen Frederiksen
Study in peopleBiomarkers
Abstract
Background: Easily acquired biomarkers for the prognosis of Alzheimer's disease are crucial in the current paradigm of disease‐modifying therapies. Light reflex pupillometry (qLRP) measures distinct midbrain functions, and actigraphy measures circadian rhythm and activity. Both have been shown to be altered in AD.
